Department of Pathology, West China Hospital, Sichuan University, No. 37 GuoXue Xiang, Chengdu, 610041, Sichuan, China.
Department of Pathology, School of Basic Medical Science & Third Hospital, Peking University Health Science Center, Beijing, China.
Int J Hematol. 2023 Jul;118(1):131-134. doi: 10.1007/s12185-023-03553-7. Epub 2023 Feb 3.
ALK-positive anaplastic large-cell lymphoma (ALK + ALCL) is characterized by expression of ALK and CD30. The current World Health Organization (WHO) classification recognizes five morphologic patterns: common, small-cell, lymphohistiocytic, Hodgkin-like, and composite. There are few reports about the morphologic transformation of ALK + ALCL. Today, we report an intriguing case of presumed transformation from common-pattern to composite-pattern (lymphohistiocytic and small-cell pattern) ALK + ALCL, with CD30 expression changing from positive to negative. This case expands understanding of morphologic transformation between different subtypes of ALK + ALCL and highlights common diagnostic pitfalls, including atypical morphology and negative CD30. Morphologic transformation of ALK + ALCL should be assigned importance, and comprehensive clinical history, histologic and immunophenotypic evaluation are vital to rendering the correct diagnosis of ALK + ALCL.
间变性大细胞淋巴瘤(ALK+ALCL)的特征是 ALK 和 CD30 的表达。目前的世界卫生组织(WHO)分类承认五种形态模式:常见型、小细胞型、淋巴组织细胞型、霍奇金样型和复合型。关于 ALK+ALCL 的形态转化的报道很少。今天,我们报告了一个有趣的病例,推测为 ALK+ALCL 从常见型向复合型(淋巴组织细胞型和小细胞型)的转化,CD30 表达从阳性变为阴性。该病例扩展了对不同亚型 ALK+ALCL 之间形态转化的认识,并强调了常见的诊断陷阱,包括非典型形态和 CD30 阴性。ALK+ALCL 的形态转化应引起重视,全面的临床病史、组织学和免疫表型评估对于正确诊断 ALK+ALCL 至关重要。